Genomic Health, Inc. (Nasdaq: GHDX) today announced results from multiple Oncotype DX® breast cancer test studies at the 38th CTRC-AACR ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE